Reveal LINQ Insertable Cardiac Monitor vs Cardiomo
AI Verdict
Choose Reveal LINQ Insertable Cardiac Monitor if…
Choose the Reveal LINQ Insertable Cardiac Monitor if long-term, continuous, and discreet cardiac monitoring is required for patients with infrequent or unexplained symptoms such as syncope, palpitations, or suspected atrial fibrillation. This implantable device offers up to 4.5 years of battery life and is MRI compatible, making it suitable for extended diagnostic periods where other monitoring methods have been inconclusive.
View Reveal LINQ Insertable Cardiac Monitor →Choose Cardiomo if…
Choose Cardiomo if you need a non-invasive, medical-grade wearable for continuous remote heart health monitoring, particularly for elderly patients or those at risk of cardiovascular diseases who benefit from real-time alerts to themselves, caregivers, and clinicians. Its focus on vital sign monitoring (ECG, heart rate, respiration, skin temperature) and AI-powered disease detection with a mobile app makes it ideal for proactive management and timely intervention.
View Cardiomo →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ Insertable Cardiac Monitor | Cardiomo |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator. | Cloud-based with wearable device and mobile app |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo, as a wearable patch, offers a non-invasive and generally more user-friendly experience for continuous monitoring compared to an insertable cardiac monitor like the Medtronic LINQ II. While both offer mobile app integration for data transmission, the implantation procedure for Tool A presents a higher barrier to initial usability.
Clinical Value
Reveal LINQ Insertable Cardiac MonitorThe Medtronic LINQ II, an insertable cardiac monitor, provides long-term, continuous, and highly accurate ECG monitoring with advanced AI algorithms specifically designed to reduce false alerts for conditions like atrial fibrillation and syncope. Its FDA clearance and extensive clinical evidence from a major medical device company like Medtronic suggest a more robust clinical validation and higher diagnostic yield for infrequent but critical cardiac events.
Pricing & Value
TieBoth companies require direct contact for current pricing, making a direct comparison difficult. While Cardiomo previously offered a publicly listed price, it is no longer current. The value proposition for each tool is also different, with Tool A being an implantable device and Tool B a wearable patch, catering to potentially different patient needs and healthcare settings.
Enterprise Readiness
Reveal LINQ Insertable Cardiac MonitorMedtronic, as a global leader in medical technology, has established infrastructure and a comprehensive CareLinku2122 network for managing and monitoring implanted cardiac devices, indicating strong enterprise readiness. Their remote programming capabilities and extensive support resources for clinicians further enhance their suitability for large-scale healthcare systems.
Innovation
Reveal LINQ Insertable Cardiac MonitorMedtronic's AccuRhythmu2122 AI algorithms, which utilize deep learning to significantly reduce false alerts and enhance diagnostic accuracy, represent a notable innovation in insertable cardiac monitoring. The remote programming capabilities of the LINQ II ICM also demonstrate advanced technological innovation for improved patient management.
Support & Docs
Reveal LINQ Insertable Cardiac MonitorMedtronic provides extensive support and documentation for the LINQ II ICM, including patient brochures, user guides, clinician manuals, and educational resources through platforms like Medtronic Academy. Their established customer service and technical support channels are also indicative of a robust support system.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ Insertable Cardiac Monitor | Cardiomo |
|---|---|---|
| Description | The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope. | Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Company | Medtronic | Cardiomo, Inc. |
| Key Features | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting) | Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days) |
| Specialties | Cardiology, Pediatrics | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ Insertable Cardiac Monitor and Cardiomo.